IGF::OT::IGF CORE INFRASTRUCTURE SUPPORT FOR SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) PERIOD OF PERFORMANCE: 05/01/2015 TO 04/30/2017

SEER 计划于 1972 年启动，旨在响应国家癌症计划的要求，评估美国癌症负担的严重程度，并确定与癌症风险和/或患者生存相关的因素。 SEER 计划的目标包括： 1. 定期收集和报告癌症发病率的估计值。 2. 监测年度癌症发病率趋势，以识别按地理、人口和社会特征定义的人口亚组中发生的特定癌症形式的异常变化。 3. 提供有关诊断时疾病范围随时间变化、治疗趋势以​​及癌症患者生存变化的持续信息。 4. 确定可能的医源性癌症（即由癌症治疗引起的癌症）的发生。 5. 作为国家癌症研究所的研究资源，针对当前的癌症控制问题以及与 SEER 计划运作相关的问题进行研究。

The SEER Program was initiated in 1972 in response to requirements of the National Cancer Program for assessing the magnitude of the cancer burden in the United States, and for identifying factors related to cancer risk and/or patient survival. The SEER Program has among its objectives: 1. To assemble and report, on a periodic basis, estimates of cancer incidence. 2. To monitor annual cancer incidence trends to identify unusual changes in specific forms of cancer occurring in population subgroups defined by geographic, demographic, and social characteristics. 3. To provide continuing information on changes over time in extent of disease at diagnosis, trends in therapy, and changes in cancer patient survival. 4. To identify the occurrence of possible iatrogenic cancers, i.e., cancers that are caused by cancer therapy. 5. To serve as a research resource to the National Cancer Institute, and conduct studies dealing with current cancer control issues as well as problems related to the operation of the SEER Program.